Alnylam Pharmaceuticals
To those who say "impossible, impractical, unrealistic," we say: "CHALLENGE ACCEPTED."We are developing new technologies and a brand-new class of innovative medicines called "RNAi therapeutics" to treat rare diseases. Alnylam was founded in 2002 based on a Nobel Prize winning breakthrough in biology - the discovery of RNA interference and a bold vision that this discovery could be used to silence disease-causing genes upstream of today's medicines. We are relentless in our pursuit of new treatments. Because patients shouldn't have to wait for hope. Alnylam is a global and diverse company of more than 500 people with 8 programs in clinical development, including 3 late-stage programs. We are based in Cambridge, MA with offices in Maidenhead UK, Zug Switzerland and Norton, MA.
About Alnylam Pharmaceuticals
To those who say "impossible, impractical, unrealistic," we say: "CHALLENGE ACCEPTED."We are developing new technologies and a brand-new class of innovative medicines called "RNAi therapeutics" to treat rare diseases. Alnylam was founded in 2002 based on a Nobel Prize winning breakthrough in biology - the discovery of RNA interference and a bold vision that this discovery could be used to silence disease-causing genes upstream of today's medicines. We are relentless in our pursuit of new treatments. Because patients shouldn't have to wait for hope. Alnylam is a global and diverse company of more than 500 people with 8 programs in clinical development, including 3 late-stage programs. We are based in Cambridge, MA with offices in Maidenhead UK, Zug Switzerland and Norton, MA.
Social Media
Technologies
Frequently Asked Questions
What does Alnylam Pharmaceuticals do?
To those who say "impossible, impractical, unrealistic," we say: "CHALLENGE ACCEPTED."We are developing new technologies and a brand-new class of innovative medicines called "RNAi therapeutics" to treat rare diseases. Alnylam was founded in 2002 based on a Nobel Prize winning breakthrough in biology - the discovery of RNA interference and a bold vision that this discovery could be used to silence disease-causing genes upstream of today's medicines. We are relentless in our pursuit of new treatments. Because patients shouldn't have to wait for hope. Alnylam is a global and diverse company of more than 500 people with 8 programs in clinical development, including 3 late-stage programs. We are based in Cambridge, MA with offices in Maidenhead UK, Zug Switzerland and Norton, MA.
How can I contact Alnylam Pharmaceuticals?
Visit their website at alnylam.com for more information.
Where is Alnylam Pharmaceuticals located?
Cambridge, United States
What industry is Alnylam Pharmaceuticals in?
biotechnology-research
How many employees does Alnylam Pharmaceuticals have?
1000-5000
When was Alnylam Pharmaceuticals founded?
2002
Looking for More Company Information?
Discover more innovative companies in our comprehensive directory.
Browse All Companies